Olon completed the acquisition of Huvepharma Italia.

Olon, an international Generic API supplier, completed the acquisition of Huvepharma Italia, a global pharmaceutical company. Financial terms were not disclosed. "We recognized in Huvepharma Italia all the right characteristics. The acquisition supports the implementation of the Group's medium to long term strategy and the achievement of our business objectives. We will capitalize on the integration with Olon's existing manufacturing network, which already includes 12 sites worldwide and 7 integrated and interconnected research centers, with our consolidated customer portfolio, which includes all the major pharmaceutical companies in the market, and our solid reputation as a partner and API supplier. The objective of the transaction is to significantly increase our overall API production capacity by unlocking the potential of the Garessio site," Paolo Tubertini, Olon CEO.